Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Childhood
  - AverageAgeOfOnset:
      value: Infancy
  - AverageAgeOfOnset:
      value: Neonatal
  Children:
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '3546'
            Source: HGNC
          - Reference: '300841'
            Source: OMIM
          Label: coagulation factor VIII
          Symbol: F8
      Label: Severe hemophilia A
      ORPHAcode: '169802'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '3546'
            Source: HGNC
          - Reference: '300841'
            Source: OMIM
          Label: coagulation factor VIII
          Symbol: F8
      Label: Moderate hemophilia A
      ORPHAcode: '169805'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '3546'
            Source: HGNC
          - Reference: '300841'
            Source: OMIM
          Label: coagulation factor VIII
          Symbol: F8
      Label: Mild hemophilia A
      ORPHAcode: '169808'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '3546'
            Source: HGNC
          - Reference: '300841'
            Source: OMIM
          Label: coagulation factor VIII
          Symbol: F8
      Label: Bleeding disorder in hemophilia A carriers
      ORPHAcode: '177926'
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '306700'
    Source: OMIM
  Label: Hemophilia A
  ORPHAcode: '98878'
  ORPHApacketId: '98878'
  PURL: http://www.orpha.net/ORDO/Orphanet_98878
  Parents:
  - Parent:
    - Label: Hemophilia
      ORPHAcode: '448'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001386
      HPOTerm: Joint swelling
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002829
      HPOTerm: Arthralgia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003125
      HPOTerm: Reduced factor VIII activity
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0005261
      HPOTerm: Joint hemorrhage
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0011889
      HPOTerm: Bleeding with minor or no trauma
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001907
      HPOTerm: Thromboembolism
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0007420
      HPOTerm: Spontaneous hematomas
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0030140
      HPOTerm: Oral cavity bleeding
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002239
      HPOTerm: Gastrointestinal hemorrhage
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0009811
      HPOTerm: Abnormality of the elbow
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0012233
      HPOTerm: Intramuscular hematoma
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0030746
      HPOTerm: Intraventricular hemorrhage
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0002170
      HPOTerm: Intracranial hemorrhage
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0012223
      HPOTerm: Splenic rupture
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 20301578[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: https://www.francecoag.org/SiteWebPublic/public/stats/stats_page.jsp?stat2=on
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 20301578[PMID]_19845775[PMID]_ ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: European Medicines Agency 2018[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Africa
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Albania
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Algeria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Argentina
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Armenia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Azerbaijan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Bangladesh
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Belarus
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Belize
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Bolivia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Bosnia and Herzegovina
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Brazil
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Chile
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Colombia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Costa rica
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Cuba
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Cyprus
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Dominican Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Ecuador
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Egypt
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: El Salvador
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Eritrea
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Guatemala
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Honduras
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Hungary
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: India
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Indonesia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iran, Islamic Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iraq
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Israel
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Jamaica
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Jordan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Kenya
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Korea, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Lebanon
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Lesotho
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Luxembourg
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: North Macedonia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Malaysia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Malta
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Mexico
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Moldova, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Mongolia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Morocco
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Nepal
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: New Zealand
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Nicaragua
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Nigeria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Pakistan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Palestinian Territory, occupied
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Panama
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Paraguay
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Peru
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Philippines
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Qatar
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Romania
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Russian Federation
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Saudi Arabia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Senegal
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Serbia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Sierra leone
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Singapore
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: South Africa
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Sri Lanka
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Sudan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Thailand
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Togo
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Tunisia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Turkey
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Ukraine
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Uruguay
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Uzbekistan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Venezuela
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Viet Nam
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Zimbabwe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Georgia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19845775[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: Congenital Factor VIII deficiency
  - Synonym: Congenital F8 deficiency
  - Synonym: Congenital FVIII deficiency
  TextSection:
    Contents: A rare genetic hematological disorder characterized by spontaneous or
      prolonged hemorrhages due to factor VIII deficiency.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: X-linked recessive
  copyright: Orphanet (c) 2025
  creationDate: '2025-12-09 10:41:42'
  version: 1.3.42 / 4.1.8 [2025-03-03]
